ANLN and nasopharyngeal carcinoma: This study demonstrated for the first time that miR-497 is a regulator of ANLN and HSPA4L. Down-regulation of this potent tumor suppressor may result in elevated expression of ANLN and HSPA4L, leading to NPC development and progression.